C3orf80

Model summary

A cytoplasmic adaptor that promotes apoptosis and modulates proteostasis by assembling protein complexes rather than catalyzing reactions. Its single, full-length scaffold-like core supports multivalent binding that enhances caspase-driven death pathways while restraining ubiquitination of selected substrates. This soluble architecture positions the protein in the cytoplasm and explains its frequent recovery in extracellular vesicles, suggesting a role in packaging and exporting apoptotic and proteostasis cues via exosomes.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The sequence is dominated by a single InterPro signature, IPR031696 (Protein of unknown function DUF4719 family) spanning residues 2–247, essentially covering the entire polypeptide. A solitary, full-length DUF family domain without embedded catalytic motifs or transmembrane segments typically encodes a soluble adaptor/scaffold rather than an enzyme. Such architectures create multivalent surfaces that mediate selective macromolecular assemblies, which causally supports a primary molecular role in protein binding (GO:0005515).

2. 02

   From this scaffold-like foundation, I infer molecular function and pathway placement by considering how a non-enzymatic adaptor can influence cell-fate pathways.

   The reported ability to induce apoptosis is mechanistically explained if the DUF4719 scaffold recruits and organizes pro-apoptotic machinery. A scaffold that stabilizes or localizes initiator pathways upstream of caspase activation will positively regulate the apoptotic process (GO:0043065) and directly promote cysteine-type endopeptidase activity involved in apoptotic signaling (GO:2001267). The same adaptor logic can also restrain ubiquitin conjugation: by sequestering substrates or assembling complexes that limit access to E3 ligases, a scaffold can enact negative regulation of protein ubiquitination (GO:0031396). Together, these causal links—assembly of apoptotic complexes and buffering of ubiquitination—explain how a single binding-centric module can drive both apoptosis and ubiquitin pathway modulation.

3. 03

   Cellular placement follows from the absence of transmembrane domains and the soluble adaptor nature of the DUF4719 core.

   Such proteins typically reside in the cytoplasm, consistent with a cytoplasmic localization and with the need to assemble signaling and proteostasis complexes in that compartment. In addition, cytoplasmic adaptors are frequently packaged into extracellular vesicles; this provides a mechanistic route to extracellular exosome association (GO:0070062), where cargo selection can export the scaffold and its partners to the extracellular milieu.

4. 04

   These features suggest a mechanistic model: a cytoplasmic DUF4719 scaffold that nucleates apoptotic signaling nodes and proteostasis regulators.

   By concentrating initiator caspase adaptors and upstream triggers, it enhances caspase activation; by transiently shielding substrates or titrating E3 ligase assemblies, it dampens ubiquitination. Likely interaction partners include apoptotic adaptors and caspase regulators (e.g., APAF1, p53 pathway components, caspase-9), as well as ubiquitin pathway nodes (E2/E3 modules and deubiquitinase-associated assemblies). Exosomal packaging may disseminate this signaling competence beyond the originating cell, reinforcing apoptosis and proteostasis cues in recipient cells.